Preoperative diagnosis and management of inherited bleeding disorders in female adolescents and adults
暂无分享,去创建一个
[1] J. Douketis,et al. Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis , 2022, Mayo Clinic proceedings. Innovations, quality & outcomes.
[2] Y. Vinogradova,et al. Medical treatment for heavy menstrual bleeding in primary care: 10-year data from the ECLIPSE trial , 2022, The British journal of general practice : the journal of the Royal College of General Practitioners.
[3] W. Miesbach,et al. Von Willebrand Disease-Specific Aspects in Women. , 2022, Hamostaseologie.
[4] W. Cantor,et al. A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes , 2022, Canadian Medical Association Journal.
[5] M. Paulis,et al. Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders , 2022, Cells.
[6] T. Renné,et al. An Update on Safe Anticoagulation. , 2022, Hamostaseologie.
[7] Hester F. Lingsma,et al. Patient‐reported outcomes in autosomal inherited bleeding disorders: A systematic literature review , 2022, Haemophilia : the official journal of the World Federation of Hemophilia.
[8] Á. Taype-Rondan,et al. Effects of replacement therapies with clotting factors in patients with hemophilia: A systematic review and meta-analysis , 2022, PloS one.
[9] F. Peyvandi,et al. Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy , 2022, Pain and Therapy.
[10] J. Astermark,et al. International consensus recommendations on the management of people with haemophilia B , 2022, Therapeutic advances in hematology.
[11] M. Holland,et al. The lived experience of women with a bleeding disorder: A systematic review , 2022, Research and practice in thrombosis and haemostasis.
[12] Maximo J Marin,et al. Von Willebrand factor and disease: a review for laboratory professionals , 2021, Critical reviews in clinical laboratory sciences.
[13] J. Oldenburg,et al. Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study , 2021, Journal of clinical medicine.
[14] A. Ma,et al. Factor-mimetic and rebalancing therapies in hemophilia A and B: the end of factor concentrates? , 2021, Hematology. American Society of Hematology. Education Program.
[15] L. George,et al. Hemophilia gene therapy: ushering in a new treatment paradigm? , 2021, Hematology. American Society of Hematology. Education Program.
[16] R. Kadir,et al. Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy. , 2021, Hematology. American Society of Hematology. Education Program.
[17] A. Taher,et al. Clinical burden of hemophilia in older adults: Beyond bleeding risk. , 2021, Blood reviews.
[18] Y. Dargaud,et al. Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence , 2021, Journal of blood medicine.
[19] B. Wiratama,et al. Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials. , 2021, F1000Research.
[20] C. Miller. The Clinical Genetics of Hemophilia B (Factor IX Deficiency) , 2021, The application of clinical genetics.
[21] Baoyu Lei,et al. Congenital hemophilia A with low activity of factor XII: a case report and literature review , 2021, Italian Journal of Pediatrics.
[22] R. Sidonio,et al. Hemophilia B (Factor IX Deficiency). , 2021, Hematology/oncology clinics of North America.
[23] C. Königs,et al. Hemophilia treatment in 2021: Choosing the"optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. , 2021, Blood reviews.
[24] J. Astermark,et al. Identification of F8 rearrangements in carrier and non‐carrier mothers of haemophilia A patients , 2021, Haemophilia : the official journal of the World Federation of Hemophilia.
[25] M. Ragni,et al. Hemophilia A (Factor VIII Deficiency). , 2021, Hematology/oncology clinics of North America.
[26] P. Kouides,et al. Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II). , 2021, Hematology/oncology clinics of North America.
[27] O. Barel,et al. Molecular Mechanisms of Skewed X-Chromosome Inactivation in Female Hemophilia Patients—Lessons from Wide Genome Analyses , 2021, International journal of molecular sciences.
[28] E. Favaloro,et al. Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations , 2021, Journal of blood medicine.
[29] L. Patton,et al. World Workshop on Oral Medicine VII: Bleeding control interventions for invasive dental procedures in patients with inherited functional platelet disorders: A systematic review. , 2021, Oral surgery, oral medicine, oral pathology and oral radiology.
[30] M. Othman,et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH , 2021, Journal of thrombosis and haemostasis : JTH.
[31] C. McGuinn,et al. Haemophilia: factoring in new therapies , 2021, British journal of haematology.
[32] P. Kouides,et al. Regulation and importance of factor VIII levels in hemophilia A carriers , 2021, Current opinion in hematology.
[33] S. Mangles,et al. Haemophilia Carriers Experience Study (CARES): A mixed method exploration into the experience of women who are carriers of Haemophilia , 2021, Haemophilia : the official journal of the World Federation of Hemophilia.
[34] A. Jerath,et al. Tranexamic acid: current use in obstetrics, major orthopedic, and trauma surgery , 2021, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[35] J. González-Porras,et al. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia , 2021, International journal of molecular sciences.
[36] G. Castaman,et al. Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives , 2021, Journal of blood medicine.
[37] J. Middeldorp,et al. Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic review. , 2021, Blood reviews.
[38] P. Bignell,et al. Factor VIII levels and bleeding according to factor 8 (F8) mutation in pregnant carriers of haemophilia A: a multicentre retrospective cohort study , 2021, British journal of haematology.
[39] J. Kujovich,et al. Delivery and neuraxial technique outcomes in patients with hemophilia and in hemophilia carriers: a systematic review , 2021, Journal of Anesthesia.
[40] V. Arruda,et al. Gene Therapy for Inherited Bleeding Disorders , 2021, Seminars in Thrombosis and Hemostasis.
[41] R. Mustafa,et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. , 2021, Blood advances.
[42] M. Franchini,et al. Prophylactic management of patients with von Willebrand disease , 2021, Therapeutic advances in hematology.
[43] R. Sidonio,et al. Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.
[44] C. Miller,et al. Genetic causes of haemophilia in women and girls , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.
[45] L. Pérez. Hemophilia carriers and women with coagulopathies: challenges in the occupational arena. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[46] M. E. Mingot Castellano. General concepts on hemophilia A and on women carrying the disease. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[47] F. Vidal. State of the art of genetic studies in hemophilia carriers. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[48] A. Torres-Ortuño. Hemophilia carriers: quality of life and management at different life stages. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[49] María Caridad Falcón Rodríguez. Carriers of haemophilia: pregnancy, childbirth and postpartum. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[50] J. C. García-Lozano,et al. Prenatal diagnostic techniques and IVF in patients with coagulopathies , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[51] E. Santagostino,et al. X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers , 2020, European Journal of Human Genetics.
[52] S. Pasca,et al. Haemophilia A/B carriers: haemorrhagic burden of disease and open issues. , 2020, Blood transfusion = Trasfusione del sangue.
[53] P. Batty,et al. Postpartum bleeding in women with inherited bleeding disorders: a matched cohort study , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[54] F. Leebeek,et al. How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease. , 2020, Blood.
[55] E. Quint,et al. Outpatient Management of Heavy Menstrual Bleeding in Adolescent and Young Women with Inherited Platelet Function Disorders. , 2020, Journal of Pediatric and Adolescent Gynecology.
[56] J. Johnsen,et al. von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.
[57] W. Miesbach. Perioperative management for patients with von Willebrand disease: Defining the optimal approach , 2020, European journal of haematology.
[58] K. Fischer,et al. The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review , 2020, Journal of thrombosis and haemostasis : JTH.
[59] C. Djambas Khayat,et al. Heavy menstrual bleeding in women with inherited bleeding disorders , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.
[60] D. Page. Setting the scene: Historical overview of challenges and what led to advances in comprehensive care in developed countries, the Canadian experience , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.
[61] G. Castaman,et al. Hemophilia management: Huge impact of a tiny difference , 2020, Research and practice in thrombosis and haemostasis.
[62] P. Mannucci. Hemophilia therapy: the future has begun , 2020, Haematologica.
[63] S. Evans. Hematopoietic , 2020, Definitions.
[64] K. V. van Galen,et al. Menstrual and obstetrical bleeding in women with inherited platelet receptor defects—A systematic review , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.
[65] A. Iorio,et al. Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS‐Hemo): Patterns of blood sampling and patient characteristics among clinician users , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.
[66] P. Mannucci. New therapies for von Willebrand disease. , 2019, Blood advances.
[67] P. Mannucci,et al. Factor VIII replacement is still the standard of care in haemophilia A. , 2019, Blood transfusion = Trasfusione del sangue.
[68] P. Noris,et al. Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report , 2019, HemaSphere.
[69] K. Robinson,et al. Women and inherited bleeding disorders - A review with a focus on key challenges for 2019. , 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[70] S. Dunkley,et al. Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy , 2019, The Medical journal of Australia.
[71] S. Dunn,et al. No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women. , 2018, Journal of Obstetrics and Gynaecology Canada.
[72] P. James,et al. Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception? , 2018, Contraception.
[73] J. Staber,et al. The spectrum of bleeding in women and girls with haemophilia B , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.
[74] Nicoleta P. Berbec,et al. Von Willebrand Disease type 2 in pregnancy - A critical clinical association. , 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[75] A. Harris,et al. Treatment of hemophilia: A qualitative study of mothers’ perspectives , 2017, Pediatric blood & cancer.
[76] B. Moiz,et al. Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings , 2016, Scandinavian journal of clinical and laboratory investigation.
[77] M. Grootenhuis,et al. Psychosocial functioning of mothers of boys with haemophilia , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.
[78] P. James,et al. Using genetic diagnostics in hemophilia and von Willebrand disease. , 2015, Hematology. American Society of Hematology. Education Program.
[79] R. Ljung,et al. Prenatal diagnosis of haemophilia in Sweden now more commonly used for psychological preparation than termination of pregnancy , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[80] Shamim A. Mollah,et al. Normal range of bleeding scores for the ISTH‐BAT: adult and pediatric data from the merging project , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[81] R. Ljung,et al. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B , 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[82] R. Ljung,et al. Increased burden on caregivers of having a child with haemophilia complicated by inhibitors , 2014, Pediatric blood & cancer.
[83] Melissa K Cousino,et al. Parenting stress among caregivers of children with chronic illness: a systematic review. , 2013, Journal of pediatric psychology.
[84] P. James,et al. von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies , 2012, American journal of hematology.
[85] J. Platt. Women and girls , 2012 .
[86] A. James. Diagnosis and management of women with bleeding disorders – international guidelines and consensus from an international expert panel , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.
[87] A. Tosetto,et al. How I treat von Willebrand disease. , 2009, Blood.
[88] B. Siegmund,et al. Quality of life, psychosocial strains and coping in parents of children with haemophilia , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[89] R. Miller,et al. Carrier testing in haemophilia A and B: adult carriers’ and their partners’ experiences and their views on the testing of young females , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[90] V. Byams,et al. Women with bleeding disorders. , 2007, Journal of women's health.
[91] L. Zimmerman. Causes and Consequences of Critical Bleeding and Mechanisms of Blood Coagulation , 2007, Pharmacotherapy.
[92] A. James,et al. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease , 2007, Journal of thrombosis and haemostasis : JTH.
[93] N. Kanayama,et al. Congenital Blood Coagulation Factor XIII Deficiency and Successful Deliveries: A Review of the Literature , 2007, Obstetrical & gynecological survey.
[94] J. Higham,et al. Assessment of menstrual blood loss using a pictorial chart , 1990, British journal of obstetrics and gynaecology.
[95] C. Moutou,et al. ESHRE PGD Consortium data collection XIV–XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013 , 2017, Human reproduction.
[96] L. Bradley,et al. The medical management of abnormal uterine bleeding in reproductive-aged women. , 2016, American journal of obstetrics and gynecology.
[97] G. Lippi,et al. Inherited platelet disorders. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[98] H. Kawame. [Carrier testing]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[99] M. Kroll,et al. Acquired disorders of platelet function. , 2005, Hematology. American Society of Hematology. Education Program.
[100] D. Ginsburg,et al. Von Willebrand disease. , 2008, Pediatric clinics of North America.